Pacira BioSciences, Inc. (PCRX)

Pacira BioSciences Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for Pacira BioSciences stock have an average target of 26.6, with a low estimate of 8.00 and a high estimate of 57. The average target predicts an increase of 56.19% from the current stock price of 17.03.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$8.00	$26.6	$22	$57
Change	-53.02%	+56.19%	+29.18%	+234.70%

Analyst Ratings

The average analyst rating for PCRX stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jun '24	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24
Strong Buy	3	3	2	3	3	3
Buy	7	6	3	3	3	3
Hold	0	1	2	2	2	2
Sell	0	0	1	1	1	1
Strong Sell	0	0	1	1	1	1
Total	10	10	9	10	10	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Balaji Prasad Barclays	Barclays	Hold Maintains $25 → $17	Hold	Maintains	$25 → $17	-0.18%	Nov 12, 2024
Serge Belanger Needham	Needham	Strong Buy Reiterates $22	Strong Buy	Reiterates	$22	+29.18%	Nov 8, 2024
Gregory Renza RBC Capital	RBC Capital	Hold Maintains $15 → $16	Hold	Maintains	$15 → $16	-6.05%	Nov 7, 2024
Gregory Renza RBC Capital	RBC Capital	Hold Maintains $14 → $15	Hold	Maintains	$14 → $15	-11.92%	Oct 4, 2024
Glen Santangelo Jefferies	Jefferies	Strong Buy Maintains $15 → $18	Strong Buy	Maintains	$15 → $18	+5.70%	Sep 24, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

705.98M

Increased by 4.59%

from 674.98M

Revenue Next Year

668.17M

Decreased by -5.36%

from 705.98M

EPS This Year

3.08

Increased by 247.61%

from 0.89

EPS Next Year

3.13

Increased by 1.44%

from 3.08

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	421.03M	429.65M	541.53M	666.82M	674.98M	705.98M	668.17M	809.34M
Revenue Growth	24.83%	2.05%	26.04%	23.14%	1.22%	4.59%	-5.36%	21.13%
EPS	-0.27	3.33	0.92	0.34	0.89	3.08	3.13	3.89
EPS Growth	-	-	-72.37%	-63.04%	160.68%	247.61%	1.44%	24.45%
Forward PE	-	-	-	-	-	5.53	5.45	4.38
No. Analysts	-	-	-	-	-	11	11	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026	2027	2028
High	735.0M	816.7M	922.6M
Avg	706.0M	668.2M	809.3M
Low	661.5M	443.0M	639.8M

Revenue Growth

Revenue Growth	2024	2025	2026	2027	2028
High	8.9%	15.7%	38.1%
Avg	4.6%	-5.4%	21.1%
Low	-2.0%	-37.3%	-4.2%

EPS Forecast

EPS	2024	2025	2026	2027	2028
High	3.49	3.74	5.22
Avg	3.08	3.13	3.89
Low	2.67	1.62	3.07

EPS Growth

EPS Growth	2024	2025	2026	2027	2028
High	293.3%	21.4%	67.0%
Avg	247.6%	1.4%	24.5%
Low	201.3%	-47.5%	-1.8%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.